
Bombay High Court criticizes FDA for arbitrary food licence suspensions
The story in brief
The Bombay High Court criticized the Food and Drug Administration (FDA) for suspending food licences in Maharashtra without proper justification, citing a lack of transparency and accountability. The court raised concerns over the impact on small businesses and the effectiveness of food safety enforcement, highlighting tensions between regulatory bodies and judicial oversight in public health governance.